Another crucial mechanism is its ability to enhance insulin signaling in the brain
Clinical trials show measurable weight loss typically appears after 4 weeks of consistent semaglutide treatment, with stronger results by week 8 to 12
Alternative treatments: Insurers often require patients to try other weight management options before approving newer drugs
In a randomised controlled trial with over 1800 participants comparing tirzepatide to semaglutide, the tirzepatide group reported more serious adverse events (5-7% VS 3%) and higher discontinuation rates due to adverse events (6-8.5% VS 4%)
However, its always advisable to monitor your condition and B vitamin levels over time
16,18 Early concerns about pancreatic safety arose from reports of pancreatitis in animal studies with the use of sitagliptin, clinical reports of humans treated with exenatide and the detection of preneoplastic pancreatic ductal lesions in animals treated with GLP-1 receptor agonists